Article · 28 Mar 2025
Conference abstractPublished 30 Oct 2020
Renal Cell Carcinoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Research focus: Investigating Olaparib, a selective inhibitor of human poly (ADP-ribose) polymerase enzymes (PARP-1, PARP2 and PARP-3) in renal cell carcinoma. Approved by Health Canada for BRCA mutation positive ovarian cancer, and germline BRCA – mutated HER2 – negative metastatic breast cancer. Research focus on DNA repair gene mutations and studying its therapeutic potential. Renal Cell Carcinoma is among 10th most common cancer in both genders with a mortality of 4,970 out of 14,830 among women. 1 in 82 women are diagnosed with renal cell carcinoma which accounts for about (1.02%). It can present either alone or concomitant with other solid tumors such as, breast and ovarian cancer. My research area is investigating the role of BRCA mutations/ DNA repair gene mutations (BAP 1 – BRCA associated protein 1 in renal cancer) that share an overlapping occurrence. This is used to develop novel therapeutic pathways that can possibly improve overall progression free survival, and quality of life for our patients. We will talk about modifiable and non – modifiable risk factors, and how the latter can be pro – actively improved through novel research/ clinical trials. The presentation will also walk you through a real case management of concomitant breast (first diagnosis), and renal cell carcinoma (concomitant diagnosis). Thank you for your time, and please feel free to have your questions ready for me.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 28 Mar 2024
Exploring the Cellular Dynamics of Renal Cell Carcinomas: Insights and Implications
Opinion · 28 Mar 2024
Exploring the Diagnostic Potential of Cell-Free DNA in Renal Cell Carcinoma: A Promising Avenue for Early Detection and Personalized Medicine
Short communication · 30 May 2022
A Dramatic Response to Immune Checkpoint Inhibitor in a Patient with a Bulky Intra Cardiac Metastasis in Renal Cell Carcinoma
Conference abstract · 1 Oct 2021
Pattern of failure in patients with non-metastatic renal pelvis transitional cell carcinoma: A single center experience in Alexandria, Egypt
More from this journal
The newest in Journal of Health and Medical Research.
Article · 2025
Patient safety challenges culture and improvement
Article · 10 Jan 2024
The Implementation and Success of Community Based Education and Research Services and Inter-Profession Education Programme at a Rural Health Sciences Faculty in Uganda: Case of Busitema University
Perspective · 26 Apr 2023
Biochemical Prospects and Major Obstacles in Nano-Vaccinology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Health and Medical Research
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Shavy Nagpal”

